
Derived from earthworms, particularly Lumbricus rubellus and Lumbricus bimastus, Lumbrokinase is a fibrinolytic enzyme. It can break down fibrinogen (a soluble plasma protein synthesised in the liver and becomes fibrin) and fibrin (an insoluble protein that stops bleeding and wound healing). Identified in 1991, this enzyme derived from earthworms has gained attention for its potential therapeutic applications. Lumbrokinase benefits include, but are not limited to, blood clot management, heart health, and inflammation management.
Key Benefits of Lumbrokinase
Out of several lumbrokinase uses or benefits, the breakdown of fibrin, a protein involved in blood clot formation, is among the best benefits of lumbrokinase. This fibrinolytic activity underpins its diverse health benefits:
1. Cardiovascular Support
Blood Clot Reduction: Lumbrokinase helps in dissolving blood clots, potentially reducing the risk of conditions like deep vein thrombosis and pulmonary embolism.
Vascular Health: By improving blood flow, it may support overall vascular function.
2. Anti-Inflammatory Effects
Chronic Inflammation: Lumbrokinase has shown promise in reducing inflammation, which is a root cause of many chronic diseases.
3. Detox benefits of Lumbrokinase
Enhanced Circulation: Improved blood flow may facilitate the removal of metabolic waste products, supporting the body’s natural detoxification processes.
4. Therapeutic Applications
Post-Ischemic Injury: Lumbrokinase may attenuate myocardial injury through the activation of Sirt1 signalling, inhibition of NF-κB expression, and activation of FoxO1 and LC3, thereby reducing inflammation, oxidative stress, and apoptosis, and enhancing autophagy after myocardial injury.
Lumbrokinase Absorption and CYP450 Enzyme Interaction
The metabolism of substances like lumbrokinase involves the cytochrome P450 (CYP450) enzyme system, primarily located in the liver and intestines. These enzymes play a crucial role in the oxidative metabolism of various compounds, including drugs and endogenous substances.
CYP450 Enzyme Families
- CYP1, CYP2, CYP3: Responsible for the metabolism of approximately 75% of clinical drugs.
- CYP4: Involved in the metabolism of eicosanoids and fatty acids.
Genetic variations in CYP450 enzymes can lead to differences in drug metabolism, affecting drug efficacy and safety.
Pharmacogenomics and Lumbrokinase
Pharmacogenomics and enzyme therapy are related in a manner that pharmacogenomic testing, commonly known as PGx testing, can assess individual variations in CYP450 enzyme activity. Thus, providing insights into how your body may metabolise lumbrokinase. This information can guide personalized dosing and reduce the risk of adverse effects.
Book an at-home PGx test from RPh LABS and know how your body may respond to 250+ medications, especially the mental health ones.
Gender-Specific Effects of Lumbrokinase
Effects on Men
Cardiovascular Health: May support heart health by improving blood flow and reducing clot formation.
Inflammation Reduction: Potential to decrease systemic inflammation, benefiting conditions like arthritis.
Effects on Women
- Post-Ischemic Injury: It may help protect the heart after injury by turning on helpful cell signals (like Sirtuin 1 which is a key player in body’s response to stress, energy levels and potentially even aging), blocking harmful ones (like nuclear factor-kappa B which is a crucial protein group playing role in cell growth, survival, immune responses, and inflammation), and activating protective proteins (like FoxO1 and LC3). This can lower inflammation, reduce cell damage and death, and boost the heart’s ability to clean up and repair itself.
- Hormonal Considerations: Women may experience different metabolic responses due to hormonal variations affecting CYP450 enzyme activity.
Lumbrokinase in Diabetic Kidney Health
As shared by Sciencedirect, studies have demonstrated that lumbrokinase can reduce diabetic kidney disease (in rat models). This effect is believed to be facilitated through the regulation of MMPs (matrix metalloproteinases), enzymes that degrade ECMs (extracellular matrix). By modulating MMP activity, lumbrokinase may help in the degradation of excess ECMs (macromolecules that surround cells).
Considerations and Side Effects
Generally, Lumbrokinase is well-tolerated, however, some people may experience:
- Gastrointestinal Discomfort: Symptoms such as nausea, vomiting, diarrhoea, or stomach cramps.
- Allergic Reactions: Rare occurrences of rash, itching, swelling, dizziness, or difficulty breathing.
- Bleeding Risks: Due to its fibrinolytic activity, there may be an increased risk of bleeding, especially in individuals on anticoagulant therapy.
- Headaches or Dizziness: Some users have reported mild headaches or dizziness.
Individuals with liver or kidney conditions should exercise caution and consult a healthcare professional before using lumbrokinase.
Summary Table
Benefit Category | Description |
Cardiovascular Support | Major therapeutic effects of lumbrokinase include reduced clot formation and enhanced blood flow |
Anti-Inflammatory | Mitigates chronic inflammation |
Detoxification | Facilitates metabolic waste removal through improved circulation |
Therapeutic Applications | Supports recovery from ischemic injuries and chronic conditions |
Short-Term Benefits | Provides rapid relief from acute symptoms |
Long-Term Benefits | Contributes to sustained health improvements over time |
Conclusion:
Lumbrokinase is a complex enzyme derived from earthworms. As shared by the synapse, it has been found to break fibrin, reduce blood clotting and thus help in maintaining cardiovascular health. In a test on rats, this has even been shown to reduce the kidney damage caused by diabetes. Lumbrokinase is metabolized in the liver, and CYP450 enzymes play a crucial role in its metabolism. Thus, this may affect individuals differently based on CYP450 enzyme activity in their body.
Due to the variation in response, there are chances of trial and error. A pharmacogenomics test gives you insights into your genetic makeup, allowing you to know how your body may respond to medications. A PGx test from RPh LABS (a CLIA-accredited lab) shows how your body may respond to 250+ medications.
FAQs
Lumbrokinase helps prevent blood clotting. It helps maintain healthy heart by dissolving fibrin.
CYP450 enzymes are involved in metabolizing lumbrokinase and variation in this enzyme may result in varied results.
In studies on rats, lumbrokinase has been shown to reduce diabetic kidney damage. However, there is currently a lack of evidence that it has the same effect in humans.
Leave a Reply